| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |